These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9604902)

  • 1. Guidelines for approval of anti-obesity drugs affecting atherosclerosis and/or lipids. The international union of pharmacology (IUPHAR).
    Anderson JW
    Am J Cardiol; 1998 Apr; 81(8A):29F-30F. PubMed ID: 9604902
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental drugs take aim at obesity.
    Vastag B
    JAMA; 2003 Apr; 289(14):1763-4. PubMed ID: 12684341
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-obesity drugs: to be or not to be?
    Dvorak RV; Sharma AM; Astrup A
    Obes Rev; 2010 Dec; 11(12):833-4. PubMed ID: 21054758
    [No Abstract]   [Full Text] [Related]  

  • 4. Two new drugs approved for obesity.
    Johnson AM
    S D Med; 2012 Sep; 65(9):356-7. PubMed ID: 23066610
    [No Abstract]   [Full Text] [Related]  

  • 5. Lorcaserin for weight loss: insights into US Food and Drug Administration approval.
    Miller LE
    J Acad Nutr Diet; 2013 Jan; 113(1):25-30. PubMed ID: 23260720
    [No Abstract]   [Full Text] [Related]  

  • 6. Companies throw their weight behind new antiobesity drugs.
    Cahoon L
    Nat Med; 2010 Feb; 16(2):136. PubMed ID: 20134442
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison table: some FDA-approved drugs for weight management.
    Med Lett Drugs Ther; 2018 Jun; 60(1548):e98-e100. PubMed ID: 29913464
    [No Abstract]   [Full Text] [Related]  

  • 8. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval of obesity drugs: a difference in risk-benefit perceptions.
    Morrato EH; Allison DB
    JAMA; 2012 Sep; 308(11):1097-8. PubMed ID: 22990266
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecule of the month. The 'skinny' on CB1 antagonists/inverse agonists: controversial obesity drugs will not go to FDA for approval.
    Lindsley CW
    Curr Top Med Chem; 2008; 8(17):1553. PubMed ID: 19097323
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves first canine diet drug.
    Nolen RS
    J Am Vet Med Assoc; 2007 Mar; 230(5):641-2. PubMed ID: 17380625
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonincretin drugs in later-stage development.
    Zimmerman MP; Mehr SR
    Am J Manag Care; 2014 Jan; 20(1 Spec No.):E2. PubMed ID: 25618226
    [No Abstract]   [Full Text] [Related]  

  • 13. Fat pill for teens. Xenical may have the FDA's blessing, but is it a good idea?
    Gupta S
    Time; 2003 Dec 29-2004 Jan 5; 162(26):162. PubMed ID: 14722944
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA's assessment of two drugs for chronic weight management.
    Colman E; Golden J; Roberts M; Egan A; Weaver J; Rosebraugh C
    N Engl J Med; 2012 Oct; 367(17):1577-9. PubMed ID: 23050510
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA-Approved Drugs to Treat Overweight and Obesity.
    J Psychosoc Nurs Ment Health Serv; 2021 Aug; 59(8):5-6. PubMed ID: 34343052
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States.
    Aggarwal R; Vaduganathan M; Chiu N; Bhatt DL
    Prog Cardiovasc Dis; 2021; 68():97-98. PubMed ID: 34560122
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug management of obesity--efficacy versus safety.
    Astrup A
    N Engl J Med; 2010 Jul; 363(3):288-90. PubMed ID: 20647205
    [No Abstract]   [Full Text] [Related]  

  • 18. The fat of the matter.
    Nat Med; 2012 Aug; 18(8):1155. PubMed ID: 22869166
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrave--a combination of bupropion and naltrexone for weight loss.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):112-4. PubMed ID: 25372849
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA-Approved Drugs to Treat Overweight and Obesity.
    J Psychosoc Nurs Ment Health Serv; 2022 Aug; 60(8):7-8. PubMed ID: 35917244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.